Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
LifeMD Inc (LFMD) PT Raised to $8 at Cantor Fitzgerald
-
Capricor Therapeutics (CAPR) Announces 4.94M Share Offering at $4.66/sh
-
Capricor Therapeutics Announces $23 Million Registered Direct Offering
-
Adlai Nortye (ANL) Prices 2.5M Share IPO at $23/sh
-
Adlai Nortye Ltd. Announces Pricing of Initial Public Offering
-
Aston Bay Holdings Ltd. Announces Update to Brokered Financing
-
Soleno Therapeutics (SLNO) Prices 3M Share Offering at $20/sh; Concurrent Private Placement
-
Soleno Therapeutics Announces Pricing of Approximately $120 Million Underwritten Public Offering of Common Stock and Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants
-
Soleno Therapeutics (SLNO) Announces Proposes Share and Warrant Offering; Concurrent Private Placement
-
Soleno Therapeutics Announces Proposed Public Offering of Common Stock and/or Pre-Funded Warrants and a Concurrent Private Placement of Common Stock and/or Pre-Funded Warrants
-
CorMedix Inc. to Present at the Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald and Silverstein Properties Announce Joint Venture Partnership with Collins Capital Partners and Kaufman Jacobs and Closing of Construction Financing for Multifamily Opportunity Zone
-
Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conference
-
Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023
-
Clene to Present at Cantor Fitzgerald Annual Global Healthcare Conference
-
Form PRE 14A Cantor Fitzgerald Income For: Dec 05
-
Form 424B3 CANTOR FITZGERALD INFRAS
-
Fulcrum Therapeutics to Participate at the Cantor Fitzgerald Global Healthcare Conference
-
PolyPid to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Cantor Fitzgerald Starts Alector Inc. (ALEC) at Overweight, 'Leading Immuno-Neuro Platform to Drive Value from Two, Not One, Pipeline Assets'
-
Cantor Fitzgerald Starts Solid Biosciences (SLDB) at Overweight
-
AVITA Medical to Present at the Cantor Global Healthcare Conference
-
Adverum Biotechnologies to Participate in Upcoming Investor Conferences
-
NKGen Biotech to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
-
Elevar Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference
-
Maze Therapeutics to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
PAVmed and Lucid Diagnostics to Participate in Panel Presentation at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
SERA PROGNOSTICS TO PRESENT AT CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE 2023
-
Outlook Therapeutics® to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Eyenovia to Participate in Panel Discussion at Cantor Global Healthcare Conference
-
Cytek Biosciences to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Spectral AI to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
-
Eledon Pharmaceuticals to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
PDS Biotech to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
-
NeuroPace to Participate in 2023 Cantor Fitzgerald Global Healthcare Conference
-
Spero Therapeutics to Present at Cantor’s Global Healthcare 2023 Investor Conference
-
Elutia to Participate in a Panel Discussion at the Cantor Global Healthcare Conference
-
Veru to Participate in Fireside Chat at the 2023 Cantor Fitzgerald Global Healthcare Conference on September 28th, 2023
-
Gorilla Technology Group (GRRR) Announce $25M Convertible Stock Offering
-
Intra-Cellular Therapies to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Clear Street Appoints Former Morgan Stanley Technology Leader Jon Daplyn as Chief Information Officer
-
Equillium to Present at the Cantor Fitzgerald Global Healthcare & LD Micro Main Event Conferences
-
NewAmsterdam Pharma to Present at 2023 Cantor Fitzgerald Global Healthcare Conference
-
Gorilla Announces $25 Million Registered Direct Offering of Convertible Preferred Stock
-
IN8bio to Participate at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Ocugen to Participate in Panel at Cantor Fitzgerald Global Healthcare Conference 2023
-
Ovid Therapeutics to Present at the 2023 Cantor Fitzgerald Global Healthcare Conference
-
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
-
Satellos to Participate in the Cantor Fitzgerald Global Healthcare Conference 2023
-
NUTEX HEALTH ANNOUNCES PARTICIPATION IN THE 2023 CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE

